Production (Stage)
Corcept Therapeutics Incorporated
CORT
$70.90
$0.841.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.99% | -1.94% | 50.47% | 28.92% | 74.83% |
| Total Depreciation and Amortization | 158.10% | 69.12% | 72.66% | -78.98% | -79.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.26% | 73.39% | -255.69% | -3,021.05% | 10.85% |
| Change in Net Operating Assets | -201.00% | 154.31% | 40.61% | -47.56% | -217.54% |
| Cash from Operations | -78.41% | 907.30% | 39.54% | -2.61% | -8.48% |
| Capital Expenditure | -- | -- | -4,318.92% | -307.84% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.98% | -475.71% | 61.29% | -149.13% | -104.34% |
| Cash from Investing | 64.82% | -476.42% | 59.81% | -149.80% | -104.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 104.56% | 37.48% | 98.51% | 116.09% | 19.87% |
| Repurchase of Common Stock | -1,838.08% | -602.01% | -361.77% | 96.34% | -81.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7,230.20% | -695.82% | -438.61% | 98.52% | -400.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -366.54% | -140.52% | 114.36% | 83.41% | -93.92% |